Jeevan Scientific Technology Limited carries a market capitalization of 1.25B, placing it among publicly traded companies globally. Its enterprise value stands at 1.20B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 1.25B |
| Enterprise Value | 1.20B |
Jeevan Scientific Technology Limited currently has 19.92M shares outstanding.
| Shares Outstanding | 19.92M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
The price-to-sales ratio is 1.78, and the price-to-book ratio stands at 5.50.
| PE Ratio | N/A |
| PS Ratio | 1.78 |
| PB Ratio | 5.50 |
| P/TBV Ratio | 1.66 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
On an enterprise value basis, Jeevan Scientific Technology Limited trades at an EV/EBITDA multiple of 37.89 and an EV/FCF ratio of 119.36. The EV/Sales ratio of 1.95 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 37.89 provides insight into valuation relative to core operating earnings.
| EV / Sales | 1.95 |
| EV / EBITDA | 37.89 |
| EV / EBIT | 37.89 |
| EV / FCF | 119.36 |
Jeevan Scientific Technology Limited maintains a current ratio of 2.51, meaning it holds 2.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 29.18, indicating elevated leverage, while an interest coverage ratio of 1.56 demonstrates limited ability to service its debt obligations.
| Current Ratio | 2.51 |
| Quick Ratio | 0.59 |
| Debt / Equity | 29.18 |
| Debt / EBITDA | 6.71 |
| Interest Coverage | 1.56 |
Jeevan Scientific Technology Limited posts a return on equity of -0.74 and a return on invested capital of 1.89.
| Return on Equity (ROE) | -0.74 |
| Return on Assets (ROA) | -0.17 |
| Return on Invested Capital (ROIC) | 1.89 |
| Return on Capital Employed (ROCE) | -0.80 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 2.10 |
Over the trailing twelve months, Jeevan Scientific Technology Limited has paid 10.59M in income taxes, reflecting an effective tax rate of 50.60.
| Income Tax | 10.59M |
| Effective Tax Rate | 50.60 |
Jeevan Scientific Technology Limited's stock has gained approximately 86.40133% over the past 52 weeks. The 50-day moving average sits at 81.55, while the 200-day moving average is 66.74.
| Beta (5Y) | N/A |
| 52-Week Price Change | 86.40133% |
| 50-Day Moving Average | 81.55 |
| 200-Day Moving Average | 66.74 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Jeevan Scientific Technology Limited generated 615.37M in revenue and converted that into -1.59M in net income, yielding earnings per share of 0.60. EBITDA reached 31.74M, while operating income came in at 31.74M.
| Revenue | 615.37M |
| Gross Profit | 566.60M |
| Operating Income | 31.74M |
| Pretax Income | 20.92M |
| Net Income | -1.59M |
| EBITDA | 31.74M |
| EBIT | 31.74M |
| Earnings Per Share (EPS) | 0.60 |
Jeevan Scientific Technology Limited holds 116.42M in cash and equivalents against 212.84M in total debt, resulting in a net debt position of 76.54M. Total book value stands at 199.19M, with working capital of 299.76M providing operational flexibility.
| Cash & Cash Equivalents | 116.42M |
| Total Debt | 212.84M |
| Net Debt | 76.54M |
| Equity (Book Value) | 199.19M |
| Book Value Per Share | 11.63 |
| Working Capital | 299.76M |
Jeevan Scientific Technology Limited operates with a gross margin of 92.07, reflecting its pricing power and cost economics. The operating margin of 5.16 and net profit margin of -0.26 provide insight into operational efficiency.
| Gross Margin | 92.07 |
| Operating Margin | 5.16 |
| Pretax Margin | 3.40 |
| Profit Margin | -0.26 |
| EBITDA Margin | 5.16 |
Jeevan Scientific Technology Limited posts an Altman Z-Score of 3.04, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 3.04 |